REBECCA DELOACH: Open Payments
NPI 1376844290 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,100 in 52 payments from 20 companies in 2025. Trend: 2023 $761 · 2024 $698 · 2025 $1,100
Food & beverage: $1,100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $302 |
| QOL Medical, LLC | 4 | $124 |
| Madrigal Pharmaceuticals | 4 | $109 |
| Braintree Laboratories, Inc. | 4 | $91 |
| Amgen Inc. | 2 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $49 |
| NeurAxis, Inc. | 1 | $47 |
| GENZYME CORPORATION | 2 | $44 |
| PFIZER INC. | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
Products named: LINZESS, Sucraid, REZDIFFRA, SUTAB, DUPIXENT, SKYRIZI, CREON, UPLIZNA.
Industry payments across SC — which companies pay providers there.
